Adrenocortical Carcinoma Patient Information
Links shared publicly online about this topic
Adrenocortical Carcinoma
webmd.com — “Adrenocortical carcinoma is a rare tumor that affects only 1 to 2 persons per one million population. It usually occurs in adults,and the median age at diagnosis is 44 years. Although adrenal carcinoma is potentially curable at early stages,only 30% of these malignancies are confined to the adrenal gland at the time of diagnosis.[ 1 ] Radical surgical excision is the treatment of choice for ...” View full resource at webmd.com
Most Recently Shared on September 10, 2010 at 10:08 pm By:
Julie Bohlen Health Executive and Active Health Library
Adrenocortical Carcinoma - What is adrenocortical carcinoma? http://bit.ly/cIHYcN
General Information About Adrenocortical Carcinoma
cancer.gov — “Expert-reviewed information summary about the treatment of adrenocortical carcinoma.” View full resource at cancer.gov
Most Recently Shared on August 4, 2009 at 1:58 am By:
Susan Scroggins Active Health Library and Health Advocate
Adrenal carcinoma treatment information: http://bit.ly/awSrh0
Columbia Adrenal Center, Adrenocortical Cancer
cumc.columbia.edu — “Adrenocortical carcinoma is cancer of the adrenal gland. This rare tumor is potentially curable in the early stages, however, only one-third of tumors remain confined to the adrenal gland at diagnosis. When they metastasize or spread to other parts of the body, these cancers often invade neighboring organs, such as the lungs, liver, or bones.” View full resource at cumc.columbia.edu
Most Recently Shared on September 10, 2010 at 10:02 pm By:
HealthTrendster Health Executive
Adrenocortical cancer is a rare tumor that is potentially curable in the early stages. http://bit.ly/czlhkr
OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study For OSI-906 In Adrenocortical Carcinoma And Phase I/II Study In Ovarian Cancer
medicalnewstoday.com — “Osi pharmaceuticals, inc. (nasdaq: osip) announced today the initiation of two clinical trials with osi-906, the company's potential first-in-class, oral insulin-like growth factor-1 receptor (igf” View full resource at medicalnewstoday.com
Most Recently Shared on September 4, 2009 at 4:05 pm By:
OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study For OSI-906 In Adrenocortical Carcinoma And .. http://bit.ly/2q4n5o
Cushing's & Cancer: Retroperitoneal Adrenal-Sparing Surgery for the Treatment of Cushing's Syndrome Caused by Adrenocortical Adenoma: 8-Year Experience With 87 Patients
cushingshelp.blogspot.com — “The life and times of a pituitary Cushing's survivor (1987) AND a kidney cancer (Renal Cell Carcinoma) survivor (2006). I must be a Super-Woman...NOT!” View full resource at cushingshelp.blogspot.com
Most Recently Shared on March 14, 2012 at 6:39 pm By:
MaryO Patient Expert and Active Health Library
Cushing's Blog Post: Retroperitoneal Adrenal-Sparing Surgery for the Treatment of Cushing's Syndrome Caused by Adren... http://t.co/QVsNQIZY
Drug Slows Advanced Kidney Cancer - Cancer Information (Cancers, Symptoms, Treatment) on MedicineNet.com
medicinenet.com — “Information on many different cancers includes symptoms, cancer detection and prevention, and treatment options.” View full resource at medicinenet.com
Most Recently Shared on January 27, 2010 at 7:04 pm By:
New Drug Slows Advanced Kidney Cancer Title: New Drug Slows Advanced Kidney CancerCategory: Health NewsCreated: 1/26/.. http://bit.ly/93mSGI
Kidney Cancer Association - Patient Empowerment
kidneycancer.org — “Comprehensive information covers symptoms and treatment of cancers of the renal pelvis,including kidney cancer, renal cell carcinoma” View full resource at kidneycancer.org
Most Recently Shared on November 16, 2009 at 9:30 pm By:
Tivantinib Extends Time to Progression in HCC Patients
onclive.com — “Treatment with tivantinib produced a 56% improvement in time-to-progression (TTP) in patients with hepatocellular carcinoma (HCC) (hazard ratio = 0.64; P = .04), according to information released by ArQule, which is developing tivantinib.” View full resource at onclive.com
Most Recently Shared on March 19, 2012 at 7:10 pm By:
Tivantinib Extends Time to Progression in HCC Patients http://t.co/6vgrZAl3
Revolutionary drug could be new hope for adrenal cancer patients
physorg.com — “TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands.” View full resource at physorg.com
Most Recently Shared on September 22, 2009 at 5:06 pm By:
Revolutionary drug could be new hope for adrenal cancer patients http://bit.ly/aaLdN
Percutaneous Radiofrequency Ablation of Liver Tumors: eMedicine Clinical Procedures
emedicine.medscape.com — “Overview: Percutaneous radio frequency ablation (RFA) is an exciting approach to destroying inoperable primary or metastasis tumors in the liver.1 In the treatment of hepatocellular carcinoma (HCC), less than 40% of patients are candidates for surgery, ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 16, 2010 at 5:26 am By:
Percutaneous radio frequency ablation may be used to destroy inoperable tumors in the liver. Need more information? http://bit.ly/bKYLbP
NCI Cancer Bulletin for July 13, 2010 - National Cancer Institute
cancer.gov — “NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.” View full resource at cancer.gov
Most Recently Shared on July 14, 2010 at 12:36 pm By:
NCI Cancer Bulletin Health News
Featured clinical trial: Targeting HER2 in the treatment of ductal carcinoma in situ: http://bit.ly/bEZ3VX
NCI Cancer Bulletin for May 4, 2010 - National Cancer Institute
cancer.gov — “NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.” View full resource at cancer.gov
Most Recently Shared on May 4, 2010 at 9:06 pm By:
NCI Cancer Bulletin Health News
Breast tissues may express biomarkers linked to DCIS recurrence: http://bit.ly/cOmeys
Surgery Medical News about Laparoscopy
mdlinx.com — “Laparoscopic Resection is Inappropriate in Patients with Known or Suspected Adrenocortical Carcinoma” View full resource at mdlinx.com
Most Recently Shared on April 12, 2010 at 8:11 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Laparoscopic Resection is Inappropriate in Patients with Known or Suspected Adrenocortical Carcinoma: World J... http://bit.ly/9G1fSo #SURG
Kidney Cancer Association - Newsletter
kidneycancer.org — “Comprehensive information covers symptoms and treatment of cancers of the renal pelvis,including kidney cancer, renal cell carcinoma” View full resource at kidneycancer.org
Most Recently Shared on August 18, 2009 at 11:06 pm By:
Kidney Cancer Health Executive
THE CURRENT EDITION OF KIDNEY CANCER NEWS IS ONLINE http://bit.ly/8Hg2v
Cirrhosis Etiology a Major Factor in Cancer Risk - QualityPoint Technologies
qualitypointtech.net — “Patients with cirrhosis are at a significantly higher risk of cancer - not just hepatocellular carcinoma (HCC) but extrahepatic cancers (EHC) too - and a new study by U.S. researchers adds to what's already known about those risks. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on January 3, 2011 at 8:00 pm By:
Cirrhosis Etiology a Major Factor in Cancer Risk: Patients with cirrhosis are at a significantly higher risk of ca... http://bit.ly/f85IxD
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Julie Bohlen
Health content professional with MBA in heathcare management. Sharing quality health resources and news. On executive team at OrganizedWisdom.
-
Susan Scroggins
Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.
-
HealthTrendster
Sharing health news and trends.
Advertisement
